Rationality of Antihypertensive Therapy and Blood Pressure Control in Comorbid Inpatients
DOI:
https://doi.org/10.37287/ijghr.v8i5.2469Keywords:
antihypertensive, blood pressure control, comorbidity, rational prescribing, retrospective cohortAbstract
Hypertension management in patients with comorbidities requires drug selection and dosing that are consistent with clinical conditions, organ function, and evidence-based recommendations. Inappropriate therapy may compromise blood pressure control and increase treatment-related risk. To evaluate the rationality of antihypertensive therapy and its association with blood pressure control among hospitalised patients with hypertension and comorbidities. An analytical retrospective cohort study used medical records from January to August 2025 at a public hospital in Central Java, Indonesia. Total sampling identified 76 eligible patients. Rational therapy required concordant assessments of right patient, right drug, and right dose. Blood pressure control was defined as a final measurement below 140/90 mmHg. Descriptive statistics, the Wilcoxon signed-rank test, and Fisher’s exact test were used. The mean age was 59.37 ± 13.01 years and 51.3% were male. Overall therapy was rational in 68 patients (89.5%); right-patient and right-dose criteria were each fulfilled in 98.7%, while right-drug criteria were fulfilled in 89.5%. Mean blood pressure declined from 187.39/100.24 mmHg to 133.07/81.89 mmHg (p<0.001). Forty-seven patients (61.8%) achieved control. Control occurred in 63.2% of the rational group and 50.0% of the non-rational group; the association was not statistically significant (OR 1.72; 95% CI 0.40–7.49; p=0.472). Most antihypertensive regimens met the documented rationality criteria and blood pressure improved substantially during hospitalisation. Although control was more frequent with rational therapy, the association was inconclusive because the non-rational group was small and inpatient outcomes were influenced by multiple clinical factors.
References
Abdelkader, N. N., Awaisu, A., Elewa, H., & El Hajj, M. S. (2023). Prescribing patterns of antihypertensive medications: A systematic review of literature between 2010 and 2020. Exploratory Research in Clinical and Social Pharmacy, 11, 100315. https://doi.org/10.1016/j.rcsop.2023.100315
Abegaz, T. M., Shehab, A., Gebreyohannes, E. A., Bhagavathula, A. S., & Elnour, A. A. (2017). Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine, 96(4), e5641. https://doi.org/10.1097/MD.0000000000005641
American Diabetes Association Professional Practice Committee. (2024). 10. Cardiovascular disease and risk management: Standards of Care in Diabetes—2024. Diabetes Care, 47(Suppl. 1), S179–S218. https://doi.org/10.2337/dc24-S010
Bress, A. P., Anderson, T. S., Flack, J. M., Ghazi, L., Hall, M. E., Laffer, C. L., Still, C. H., Taler, S. J., Zachrison, K. S., & Chang, T. I. (2024). The management of elevated blood pressure in the acute care setting: A scientific statement from the American Heart Association. Hypertension, 81(8), e94–e106. https://doi.org/10.1161/HYP.0000000000000238
Burnier, M., & Egan, B. M. (2019). Adherence in hypertension. Circulation Research, 124(7), 1124–1140. https://doi.org/10.1161/CIRCRESAHA.118.313220
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., Lackland, D. T., Laffer, C. L., Newton-Cheh, C., Smith, S. M., Taler, S. J., Textor, S. C., Turan, T. N., & White, W. B. (2018). Resistant hypertension: Detection, evaluation, and management. Hypertension, 72(5), e53–e90. https://doi.org/10.1161/HYP.0000000000000084
Carey, R. M., Wright, J. T., Jr., Taler, S. J., & Whelton, P. K. (2021). Guideline-driven management of hypertension: An evidence-based update. Circulation Research, 128(7), 827–846. https://doi.org/10.1161/CIRCRESAHA.121.318083
Cheung, A. K., Whelton, P. K., Muntner, P., Schutte, A. E., Moran, A. E., Williams, B., Sarafidis, P., Chang, T. I., Daskalopoulou, S. S., Flack, J. M., Jennings, G., Juraschek, S. P., Kreutz, R., Mancia, G., Nesbitt, S., Ordunez, P., Padwal, R., Persu, A., Rabi, D., … Mann, J. F. E. (2023). International consensus on standardized clinic blood pressure measurement: A call to action. The American Journal of Medicine, 136(5), 438–445.e1. https://doi.org/10.1016/j.amjmed.2022.12.015
de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P., & Bakris, G. (2022). Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association and Kidney Disease: Improving Global Outcomes. Diabetes Care, 45(12), 3075–3090. https://doi.org/10.2337/dci22-0027
Du, L. P., Cheng, Z. W., Zhang, Y. X., Li, Y., & Mei, D. (2018). The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: A meta-analysis. Journal of Clinical Hypertension, 20(5), 902–907. https://doi.org/10.1111/jch.13272
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016). Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. The Lancet, 387(10022), 957–967. https://doi.org/10.1016/S0140-6736(15)01225-8
Kalinić, D., Škrbić, R., Vulić, D., Stojaković, N., Stoisavljević-Šatara, S., Stojiljković, M. P., Marković-Peković, V., Golić Jelić, A., Pilipović-Broćeta, N., Wong, N. D., & Godman, B. (2022). Trends in antihypertensive medicine utilization in the Republic of Srpska, Bosnia and Herzegovina: An eleven-year follow-up. Frontiers in Pharmacology, 13, 889047. https://doi.org/10.3389/fphar.2022.889047
KDIGO Blood Pressure Work Group. (2021). KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney International, 99(3S), S1–S87. https://doi.org/10.1016/j.kint.2020.11.003
Li, Y. T., Wang, H. H. X., Liu, K. Q. L., Lee, G. K. Y., Chan, W. M., Griffiths, S. M., & Chen, R. L. (2016). Medication adherence and blood pressure control among hypertensive patients with coexisting long-term conditions in primary care settings: A cross-sectional analysis. Medicine, 95(20), e3572. https://doi.org/10.1097/MD.0000000000003572
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., Azizi, M., Benetos, A., Borghi, C., Hitij, J. B., Cifkova, R., Coca, A., Cornelissen, V., Cruickshank, J. K., Cunha, P. G., ... Kjeldsen, S. E. (2023). 2023 ESH Guidelines for the management of arterial hypertension. Journal of Hypertension, 41(12), 1874–2071. https://doi.org/10.1097/HJH.0000000000003480
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., Hanssen, H., Harris, J., Lauder, L., McManus, R. J., Molloy, G. J., Rahimi, K., Regitz-Zagrosek, V., Rossi, G. P., Sandset, E. C., ... ESC Scientific Document Group. (2024). 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal, 45(38), 3912–4018. https://doi.org/10.1093/eurheartj/ehae178
Muntner, P., Shimbo, D., Carey, R. M., Charleston, J. B., Gaillard, T., Misra, S., Myers, M. G., Ogedegbe, G., Schwartz, J. E., Townsend, R. R., Urbina, E. M., Viera, A. J., White, W. B., & Wright, J. T. (2019). Measurement of blood pressure in humans: A scientific statement from the American Heart Association. Hypertension, 73(5), e35–e66. https://doi.org/10.1161/HYP.0000000000000087
NCD Risk Factor Collaboration (NCD-RisC). (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet, 398(10304), 957–980. https://doi.org/10.1016/S0140-6736(21)01330-1
Rashikh, M. A., Alruways, A. F., Alotaibi, H. B., Alotaibi, N. A., Almarshad, F., Alsaab, S. M., & Alotaibi, G. (2023). Blood pressure control and prescription pattern of antihypertensive drugs in adherence to the 2020 International Society of Hypertension global hypertension practice guidelines in Saudi Arabia: A retrospective study. Cureus, 15(2), e34965. https://doi.org/10.7759/cureus.34965
Rastogi, R., Sheehan, M. M., Hu, B., Shaker, V., Kojima, L., & Rothberg, M. B. (2021). Treatment and outcomes of inpatient hypertension among adults with noncardiac admissions. JAMA Internal Medicine, 181(3), 345–352. https://doi.org/10.1001/jamainternmed.2020.7501
Tucker, K. L., Sheppard, J. P., Stevens, R., Bosworth, H. B., Bove, A., Bray, E. P., Earle, K., George, J., Godwin, M., Green, B. B., Hebert, P., Hobbs, F. D. R., Kantola, I., Kerry, S. M., Leiva, A., Magid, D. J., Mant, J., Margolis, K. L., McKinstry, B., ... McManus, R. J. (2017). Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis. PLOS Medicine, 14(9), e1002389. https://doi.org/10.1371/journal.pmed.1002389
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., Wainford, R. D., Williams, B., & Schutte, A. E. (2020). 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension, 75(6), 1334–1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
Vrijens, B., Antoniou, S., Burnier, M., de la Sierra, A., & Volpe, M. (2017). Current situation of medication adherence in hypertension. Frontiers in Pharmacology, 8, 100. https://doi.org/10.3389/fphar.2017.00100
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Jr., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Jr., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., Sr., ... Wright, J. T., Jr. (2018). 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension, 71(6), e13–e115. https://doi.org/10.1161/HYP.0000000000000065
World Health Organization. (2021). Guideline for the pharmacological treatment of hypertension in adults. https://www.who.int/publications/i/item/9789240033986
World Health Organization. (2023). Global report on hypertension: The race against a silent killer. https://www.who.int/publications/i/item/9789240081062
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Indonesian Journal of Global Health Research

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.








